interstitial lung disease

Picture the lung not as a hollow balloon but as a delicate sponge, where the walls between the tiny air sacs are thin enough for oxygen to slip across. Interstitial lung disease, or ILD, is a large family of conditions in which those walls become inflamed, thickened, or scarred. As the sponge stiffens, it cannot stretch as freely with each breath, and oxygen has a harder time crossing into the blood.

ILD is not a single illness but an umbrella covering more than two hundred disorders. Some have a known trigger, such as inhaled dust, certain drugs, or an autoimmune disease. Others, like idiopathic pulmonary fibrosis, arise with no identifiable cause. Despite their varied origins, many share a common path of injury to the alveolar walls followed by inflammation or fibrosis.

Typical symptoms are slowly worsening breathlessness on exertion and a persistent dry cough. On examination, doctors often hear fine crackles at the lung bases, and lung-function tests usually show a restrictive pattern with reduced gas transfer. High-resolution CT scanning is central to sorting the many subtypes, because the precise pattern of scarring often points toward the diagnosis and the likely course.

Prognosis and treatment depend heavily on the specific subtype. Some inflammatory forms respond well to anti-inflammatory or immune-suppressing drugs, while progressively fibrotic forms may instead call for antifibrotic medicines. Distinguishing reversible inflammation from established scarring is one of the central tasks of ILD care, and it usually requires a team reviewing the clinical picture, imaging, and sometimes tissue together.